Please assess the completion status of the following clinical trial:

Trial Title: A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males, or females of nonchildbearing potential~* 18 to 70 years of age~* Type 2 Diabetes Mellitus~* Liver fat \>/=8% by MRI-PDFF~* On stable dose of metformin monotherapy for at least 2 months (at a dose of at least 500 mg daily)~Exclusion Criteria:~* History of other liver disease~* Unable to have an MRI performed~* Significant weight loss in the previous month and/or participant in current weight loss program~* History of diabetic complications with end-organ damage

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Palacebo
- Low Dose (Type: EXPERIMENTAL): 150 mg
- High Dose (Type: EXPERIMENTAL): 300 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).